Skip to content
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Menu
Home
About Us
Resources
Profiles Metrics
Authors Directory
Institutions Directory
Top Authors
Top Institutions
Top Sponsors
AI Digest
Contact Us
Publication Details
AFRICAN RESEARCH NEXUS
SHINING A SPOTLIGHT ON AFRICAN RESEARCH
STrengthening the Reporting of OBservational studies in Epidemiology - Molecular Epidemiology (STROBE-ME): An extension of the STROBE statement
European Journal of Clinical Investigation, Volume 42, No. 1, Year 2012
Notification
URL copied to clipboard!
Description
Advances in laboratory techniques have led to a rapidly increasing use of biomarkers in epidemiological studies. Biomarkers of internal dose, early biological change, susceptibility and clinical outcomes are used as proxies for investigating interactions between external and/or endogenous agents and body components or processes. The need for improved reporting of scientific research led to influential statements of recommendations such as the STrengthening Reporting of OBservational studies in Epidemiology (STROBE) statement. The STROBE initiative established in 2004 aimed to provide guidance on how to report observational research. Its guidelines provide a user-friendly checklist of 22 items to be reported in epidemiological studies, with items specific to the three main study designs: cohort studies, case-control studies and cross-sectional studies. The present STrengthening the Reporting of OBservational studies in Epidemiology -Molecular Epidemiology (STROBE-ME) initiative builds on the STROBE statement implementing nine existing items of STROBE and providing 17 additional items to the 22 items of STROBE checklist. The additions relate to the use of biomarkers in epidemiological studies, concerning collection, handling and storage of biological samples; laboratory methods, validity and reliability of biomarkers; specificities of study design; and ethical considerations. The STROBE-ME recommendations are intended to complement the STROBE recommendations. © 2011 The Authors. European Journal of Clinical Investigation © 2011 Stichting European Society for Clinical Investigation Journal Foundation.
Authors & Co-Authors
Gallo, Valentina
United Kingdom, London
Imperial College London
United Kingdom, London
London School of Hygiene & Tropical Medicine
Egger, Matthias
Switzerland, Bern
University of Bern
McCormack, Valerie Ann
France, Lyon
Centre International de Recherche Sur le Cancer
Ioannidis, John P.A.
United States, Palo Alto
Stanford University
Greece, Ioannina
Faculty of Medicine
Kirsch-Volders, Micheline
Belgium, Brussels
Vrije Universiteit Brussel
Matullo, Giuseppe
Italy, Turin
Università Degli Studi Di Torino
Phillips, David D. H.
United Kingdom, London
The Institute of Cancer Research
Stro̊mberg, Ulf
Sweden, Lund
Lunds Universitet
Vermeulen, Roel C.H.
Netherlands, Utrecht
Universiteit Utrecht
Wild, Christopher Paul
France, Lyon
Centre International de Recherche Sur le Cancer
Porta, Miquel S.
Spain, Barcelona
Institut Municipal D'investigacio Medica
Vineis, Paolo
United Kingdom, London
Mrc Centre for Environment and Health
Statistics
Citations: 55
Authors: 12
Affiliations: 15
Identifiers
Doi:
10.1111/j.1365-2362.2011.02561.x
ISSN:
13652362
Study Design
Cross Sectional Study
Cohort Study
Case-Control Study